What is WAT stock price today?

WAT (Waters Corporation) stock is trading at $394.03 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is WAT stock going up or down today?

WAT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy WAT stock now?

The decision to buy WAT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is WAT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for WAT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is WAT stock overvalued or undervalued?

WAT currently trades at a P/E ratio of 36.25, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if WAT is fairly priced.

What is WAT's P/E ratio?

WAT has a price-to-earnings (P/E) ratio of 36.25, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is WAT's market cap?

WAT (Waters Corporation) has a market capitalization of $23.46 billion, making it a mid-cap stock.

What is WAT's price to book ratio?

WAT trades at a price-to-book (P/B) ratio of 10.06, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does WAT pay dividends?

WAT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is WAT's dividend yield?

WAT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is WAT stock a good long-term investment?

WAT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is WAT's revenue growth rate?

WAT has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, WAT is profitable with a profit margin of 0.2%. This indicates the company generates 0.2 cents of profit for every dollar of revenue.

What are the risks of investing in WAT?

Key risks for WAT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does WAT compare to its competitors?

Compare WAT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize WAT's performance and positioning.

What is WAT's stock price target for 2026?

Our AI model provides price targets for WAT based on fundamental analysis: Bull case $512.24 (+30%), Base case $453.13 (+15%), Bear case $354.63 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about WAT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for WAT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is WAT's next earnings report?

WAT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

WAT - Waters Corporation

NYSE * Healthcare * Diagnostics & Research

$394.03

+$0.35 (+0.09%)

About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

WAT Key Statistics

Market Cap

$23.46B

P/E Ratio

36.25

P/B Ratio

10.06

EPS

$10.87

Revenue Growth

+0.1%

Profit Margin

0.2%

Employees

7,600

How WAT Compares to Peers

WAT is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Rev Growth	Margin	Compare
WAT(This stock)	$23.46B	36.2	0.1%	0.2%	-
UNHUnitedHealth Group	$308.45B	17.7	0.1%	0.0%	vs UNH
JNJJohnson &	$505.28B	20.2	0.1%	0.3%	vs JNJ
LLYEli Lilly	$969.07B	52.9	0.5%	0.3%	vs LLY
PFEPfizer Inc	$143.68B	14.7	-0.1%	0.2%	vs PFE
ABBVAbbvie Inc	$388.90B	166.7	0.1%	0.0%	vs ABBV

Waters Corporation Company Information

Headquarters: 34 Maple Street, Milford, MA, United States, 01757, undefined
Website: www.waters.com
Sector: Healthcare
Industry: Diagnostics & Research

WAT - Waters Corporation

About Waters Corporation

WAT Key Statistics

How WAT Compares to Peers

Waters Corporation Company Information

WAT Lician Score

WAT Financial Snowflake

Upcoming Events for WAT